Global patent index - EP 1051184 A1

EP 1051184 A1 2000-11-15 - PHARMACEUTICAL COMPOSITION COMPRISING VANADIUM AND/OR SALTS THEREOF AND ITS USE TO TREAT BURNS

Title (en)

PHARMACEUTICAL COMPOSITION COMPRISING VANADIUM AND/OR SALTS THEREOF AND ITS USE TO TREAT BURNS

Title (de)

VANADIUM UND/ODER DEREN SALZE ENTHALTENDE PHARMAZEUTISCHE ZUSAMMENSETZUNG ZUR BEHANDLUNG VON VERBRENNUNGEN

Title (fr)

PREPARATION PHARMACEUTIQUE A BASE DE VANADIUM OU DE L'UN DE SES SELS POUR LE TRAITEMENT DES BRULURES

Publication

EP 1051184 A1 (EN)

Application

EP 99907421 A

Priority

  • EP 99907421 A
  • EP 9900483 W
  • EP 98200223 A

Abstract (en)

[origin: WO9937312A1] The present invention relates to the use of multivalent transition elements and/or salts thereof in a pharmaceutical composition to inhibit bacterial or yeast growth. Especially bacterial Pseudomonas growth is inhibited by using said pharmaceutical composition comprising vanadium and/or a salt thereof. Said vanadium or a vanadium salt is incorporated in a pharmaceutical composition as an essential element whereupon this pharmaceutical is applied for instance to burn-wound patients or patients having ulcers like diabetic foot ulcers.

IPC 1-7 (main, further and additional classification)

A61K 33/24

IPC 8 full level (invention and additional information)

A61K 33/24 (2006.01)

CPC (invention and additional information)

A61K 33/24 (2013.01)

Citation (search report)

See references of WO 9937312A1

Designated contracting state (EPC)

AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

EPO simple patent family

WO 9937312 A1 19990729; AU 2719299 A 19990809; CA 2318902 A1 19990729; EP 1051184 A1 20001115

INPADOC legal status

2003-02-05 [18D] DEEMED TO BE WITHDRAWN

- Ref Legal Event Code: 18D

- Effective date: 20020801

2000-11-15 [17P] REQUEST FOR EXAMINATION FILED

- Ref Legal Event Code: 17P

- Effective date: 20000731

2000-11-15 [AK] DESIGNATED CONTRACTING STATES:

- Ref Legal Event Code: AK

- Designated State(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE